Cargando…

HLA-DR Association in Papillary Thyroid Carcinoma

Objective: Papillary thyroid carcinoma (PTC) is the most frequent types of thyroid malignancies. Several genes may be involved in susceptibility of thyroid cancer including Human Leukocyte Antigens (HLA). The association of thyroid carcinoma with HLA alleles has been previously studied in other popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Amoli, Mahsa M., Yazdani, Nasrin, Amiri, Parvin, Sayahzadeh, Forogh, Haghpanah, Vahid, Tavangar, Seyed Mohammad, Amirzargar, Ali, Ghaffari, Hamidollah, Nikbin, Behrooz, Larijani, Bagher, Mostaan, Leila V., Bazzaz, Javad Tavakkoly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833609/
https://www.ncbi.nlm.nih.gov/pubmed/20164547
http://dx.doi.org/10.3233/DMA-2010-0683
_version_ 1782291869494935552
author Amoli, Mahsa M.
Yazdani, Nasrin
Amiri, Parvin
Sayahzadeh, Forogh
Haghpanah, Vahid
Tavangar, Seyed Mohammad
Amirzargar, Ali
Ghaffari, Hamidollah
Nikbin, Behrooz
Larijani, Bagher
Mostaan, Leila V.
Bazzaz, Javad Tavakkoly
author_facet Amoli, Mahsa M.
Yazdani, Nasrin
Amiri, Parvin
Sayahzadeh, Forogh
Haghpanah, Vahid
Tavangar, Seyed Mohammad
Amirzargar, Ali
Ghaffari, Hamidollah
Nikbin, Behrooz
Larijani, Bagher
Mostaan, Leila V.
Bazzaz, Javad Tavakkoly
author_sort Amoli, Mahsa M.
collection PubMed
description Objective: Papillary thyroid carcinoma (PTC) is the most frequent types of thyroid malignancies. Several genes may be involved in susceptibility of thyroid cancer including Human Leukocyte Antigens (HLA). The association of thyroid carcinoma with HLA alleles has been previously studied in other populations and certain HLA alleles were shown to be either predisposing or protective. The aim of this study was to determine the association between HLA-DR and papillary thyroid carcinoma in an Iranian population. Design: HLA-DR antigen frequencies were determined in patients with papillary thyroid carcinoma (N = 70) and non-related healthy controls (N=180) using PCR -SSP. Main Outcome: We found that HLA-DRB1*04 frequency was significantly higher in our patients compared to the controls [P = 0.02, OR; 1.9, 95% CI (1.04–3.57)]. Conclusions: Our results revealed HLA-DRB1*04 as predisposing factor in papillary thyroid carcinoma in Iranian population. This confirms the previous findings for associations between HLA-DRB1 and differentiated carcinomas in other populations.
format Online
Article
Text
id pubmed-3833609
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-38336092013-12-17 HLA-DR Association in Papillary Thyroid Carcinoma Amoli, Mahsa M. Yazdani, Nasrin Amiri, Parvin Sayahzadeh, Forogh Haghpanah, Vahid Tavangar, Seyed Mohammad Amirzargar, Ali Ghaffari, Hamidollah Nikbin, Behrooz Larijani, Bagher Mostaan, Leila V. Bazzaz, Javad Tavakkoly Dis Markers Other Objective: Papillary thyroid carcinoma (PTC) is the most frequent types of thyroid malignancies. Several genes may be involved in susceptibility of thyroid cancer including Human Leukocyte Antigens (HLA). The association of thyroid carcinoma with HLA alleles has been previously studied in other populations and certain HLA alleles were shown to be either predisposing or protective. The aim of this study was to determine the association between HLA-DR and papillary thyroid carcinoma in an Iranian population. Design: HLA-DR antigen frequencies were determined in patients with papillary thyroid carcinoma (N = 70) and non-related healthy controls (N=180) using PCR -SSP. Main Outcome: We found that HLA-DRB1*04 frequency was significantly higher in our patients compared to the controls [P = 0.02, OR; 1.9, 95% CI (1.04–3.57)]. Conclusions: Our results revealed HLA-DRB1*04 as predisposing factor in papillary thyroid carcinoma in Iranian population. This confirms the previous findings for associations between HLA-DRB1 and differentiated carcinomas in other populations. IOS Press 2010 2010-02-17 /pmc/articles/PMC3833609/ /pubmed/20164547 http://dx.doi.org/10.3233/DMA-2010-0683 Text en Copyright © 2010 Hindawi Publishing Corporation.
spellingShingle Other
Amoli, Mahsa M.
Yazdani, Nasrin
Amiri, Parvin
Sayahzadeh, Forogh
Haghpanah, Vahid
Tavangar, Seyed Mohammad
Amirzargar, Ali
Ghaffari, Hamidollah
Nikbin, Behrooz
Larijani, Bagher
Mostaan, Leila V.
Bazzaz, Javad Tavakkoly
HLA-DR Association in Papillary Thyroid Carcinoma
title HLA-DR Association in Papillary Thyroid Carcinoma
title_full HLA-DR Association in Papillary Thyroid Carcinoma
title_fullStr HLA-DR Association in Papillary Thyroid Carcinoma
title_full_unstemmed HLA-DR Association in Papillary Thyroid Carcinoma
title_short HLA-DR Association in Papillary Thyroid Carcinoma
title_sort hla-dr association in papillary thyroid carcinoma
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833609/
https://www.ncbi.nlm.nih.gov/pubmed/20164547
http://dx.doi.org/10.3233/DMA-2010-0683
work_keys_str_mv AT amolimahsam hladrassociationinpapillarythyroidcarcinoma
AT yazdaninasrin hladrassociationinpapillarythyroidcarcinoma
AT amiriparvin hladrassociationinpapillarythyroidcarcinoma
AT sayahzadehforogh hladrassociationinpapillarythyroidcarcinoma
AT haghpanahvahid hladrassociationinpapillarythyroidcarcinoma
AT tavangarseyedmohammad hladrassociationinpapillarythyroidcarcinoma
AT amirzargarali hladrassociationinpapillarythyroidcarcinoma
AT ghaffarihamidollah hladrassociationinpapillarythyroidcarcinoma
AT nikbinbehrooz hladrassociationinpapillarythyroidcarcinoma
AT larijanibagher hladrassociationinpapillarythyroidcarcinoma
AT mostaanleilav hladrassociationinpapillarythyroidcarcinoma
AT bazzazjavadtavakkoly hladrassociationinpapillarythyroidcarcinoma